Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF227 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | WDR76 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | THRAP3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | NEK7 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | HNRNPD | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | GAS6 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | ZNF142 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | SNRPA | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | CLASRP | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |